FDA approving drugs after fewer trials, providing less information to public, OSU studies find
The U.S. Food and Drug Administration is approving more novel pharmaceutical drugs based on single clinical trials and with less public disclosure about those trials than was the norm just…
You must be logged in to post a comment.